Upfront Neck Dissection in Organ Preservation Protocol in Head-Neck SCC : Can it be a Game Changer?

  • 0Sri Guru Ram Das University of Health sciences, 27-C, Sant Avenue, The Mall, Amritsar, Punjab 143001 India.

Summary

This summary is machine-generated.

Upfront neck dissection in head and neck squamous cell carcinoma (HNSCC) patients with advanced lymph node involvement (N2-N3a) undergoing organ preservation shows promising survival rates. Timely initiation of primary treatment post-dissection is crucial for optimal outcomes.

Area Of Science

  • Oncology
  • Head and Neck Surgery
  • Squamous Cell Carcinoma Research

Background

  • Lymph node status is a critical prognostic factor in head and neck squamous cell carcinoma (HNSCC).
  • The role of upfront neck dissection in organ preservation protocols for HNSCC remains under-researched, despite potential benefits.

Purpose Of The Study

  • To evaluate the efficacy of upfront neck dissection in patients with T1-2N2-3a HNSCC undergoing organ preservation.
  • To determine the impact of treatment timing on survival outcomes in this patient cohort.

Main Methods

  • An observational study involving 22 patients with biopsy-proven T1-2N2-3a HNSCC of the hypopharynx, oropharynx, and laryngopharynx.
  • Patients were eligible for organ preservation protocols for their primary site.
  • Primary outcome measured was the 5-year overall survival rate.

Main Results

  • The overall 5-year survival rate was 68.12%, with a 5-year disease-free survival rate of 77.2%.
  • Delayed initiation of primary treatment (>21 days post-neck dissection) significantly reduced 5-year survival rates (e.g., 20.4% at 39 days).
  • Nodal status significantly impacted 5-year survival (p=0.027), with rates of 88.8% for N2a, 54.5% for N2b, and 50% for N3a.

Conclusions

  • Upfront neck dissection is favored for a subset of T1-2N2-3a HNSCC cases eligible for organ preservation.
  • Minimizing delay between neck dissection and primary treatment initiation is critical for improving overall survival in HNSCC patients.